HOME >> BIOLOGY >> NEWS
Scripps research scientists show protein accelerates breast cancer progression in animal models

The study is being published the week of June 18, 2007 in an advanced online edition of the Proceedings of the National Academy of Sciences.

Until this study, the significance of pleiotrophin (PTN) expression in breast cancer had not been clearly established. These new findings could lead to a better understanding of the molecular pathogenesis of breast cancer and focus attention on PTN and its signaling pathway as possible targets for new cancer therapies.

The study also found that the expression of pleiotrophin activated surrounding cells to remodel the tumor microenvironment, induced tumor angiogenesis, and increased the number of receptors for different markers of aggressive breast cancers.

Breast cancers progress through stages of increasing malignancy triggered by mutations that promote their growth, said Thomas Deuel, the Scripps Research scientist whose laboratory made the discovery. The major finding of our study demonstrates both in vivo and in vitro that inappropriate expression of PTN not only promotes breast cancer progression but that by itself PTN secretion from human breast cancer cells may be sufficient to shift that progression to a more aggressive form of breast cancer.

In the study, three models were tested to determine if inappropriate expression of PTN alone was sufficient to induce breast cancer or whether the cytokine cooperates with different pathogenic mechanisms to stimulate breast cancer progression.

The new study identified PTN as one factor that activates stromal cells-cells found in the loose connective tissue-and induces several features of aggressive breast cancer. While the importance of these cancer cell-stromal cell interactions is well established, only limited progress has been made in identifying the factors that cause stromal cells to initiate tumor progression.

Our breakthrough findings demonstrate that PTN-activated stromal cells are responsible for the ultimat
'"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
20-Jun-2007


Page: 1 2

Related biology news :

1. Study led by Scripps Research scientist reveals little-known cell networks vital to circadian rhythm
2. Scripps research team sheds light on long-sought cold sensation gene
3. Scripps research study shows humans and plants share common regulatory pathway
4. Scripps research scientists identify new regulatory mechanism for critical protein signaling domain
5. Scripps research team discovers a chemical pathway that causes mice to overeat and gain weight
6. Scripps research study reveals structural dynamics of single prion molecules
7. Scripps research scientists: Compounds show significant promise against potential bioweapon toxins
8. Scripps Research study reveals new function of protein kinase pathway in tumor suppression
9. Scripps Research study reveals new activation mechanism for pain sensing channel
10. NYU, Scripps finding offers new path for treatment of diabetes
11. Reduced body temperature extends lifespan in study from the Scripps Research Institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... 15, 2019 , ... Make IVD tests faster, focus on ... was the message at the world's largest gathering of laboratory professionals and IVD ... Clinical Chemistry (AACC) Annual Scientific Meeting was held in Anaheim, CA, this month. ...
(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a leading developer ... in the 38th annual Inc. 500|5000 list of fastest growing private companies, ... must have been founded and generating revenue by March 31, 2015. Ranking in the ...
(Date:8/6/2019)... ... August 06, 2019 , ... VetStem Biopharma ... and GMP manufacturing experience. In November it spun out a human regenerative ... experience and one of the first cGMP cell manufacturing facilities in California ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from preclinical ... Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical ... change in crystallite size , Over 142% increase in particle size , ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Stem Cells Inc. (PSC) , has announced that their GMP facility for cell ... Drug Branch for manufacturing. This is an important milestone for VetStem as ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... interest to our methodology, processes, and diagnostic techniques. The patent applications titled ... IP rights including our proprietary sleep scoring methodology. The approval and success ...
Breaking Biology Technology:
Cached News: